The targeted deletion of HK2 was shown to effectively curb liver fibrosis in both in vivo and in vitro conditions, suggesting HK2 as a viable therapeutic target for liver fibrosis [16]. The gene discussed is HK2; the disease is Hepatic fibrosis.